Rat CD4+CD8+ macrophages kill tumor cells through an NKG2D- and granzyme/perforin-dependent mechanism. 2008

Tomohisa Baba, and Sari Iwasaki, and Takako Maruoka, and Akira Suzuki, and Utano Tomaru, and Hitoshi Ikeda, and Takashi Yoshiki, and Masanori Kasahara, and Akihiro Ishizu
Department of Pathology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

We previously identified a subpopulation of monocyte/macrophage lineage cells expressing both CD4 and CD8. This subpopulation was expanded in rat peripheral blood and spleen after immunization with adjuvants containing killed tuberculosis germs. CD4+CD8+ monocytes/macrophages obtained from preimmunized rats exhibited a Th1-type cytokine/chemokine profile, expressed high levels of Fas ligand, perforin, granzyme B, and NKR-P2 (rat ortholog of human NKG2D), and killed certain tumor cells. In the present study, we confirmed that CD4+CD8+ monocytes/macrophages are distinct from splenic dendritic cells (DCs) or IFN-producing killer DCs. In vitro cytotoxic assays revealed that CD4+CD8+ macrophages killed tumor cells in a cell-cell contact-dependent manner and that expression of the retinoic acid early transcript 1 (a ligand for NKG2D) made tumor cells susceptible to killing by CD4+CD8+ macrophages. Furthermore, inhibitors of granzyme and perforin significantly decreased cytotoxic activities of CD4+CD8+ macrophages. Consistent with these in vitro findings, preimmunization with adjuvants containing killed tuberculosis germs elevated the expression of granzyme B in tumor-infiltrating CD4+CD8+ macrophages and significantly inhibited the growth of inoculated tumor cells. Our current work demonstrates that CD4+CD8+ macrophages are a unique subpopulation of monocyte/macrophage lineage cells that kill tumor cells in an NKG2D- and granzyme/perforin-dependent mechanism.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D002450 Cell Communication Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP. Cell Interaction,Cell-to-Cell Interaction,Cell Communications,Cell Interactions,Cell to Cell Interaction,Cell-to-Cell Interactions,Communication, Cell,Communications, Cell,Interaction, Cell,Interaction, Cell-to-Cell,Interactions, Cell,Interactions, Cell-to-Cell
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006131 Growth Inhibitors Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth ( Cell Growth Inhibitor,Cell Growth Inhibitors,Growth Inhibitor,Growth Inhibitor, Cell,Growth Inhibitors, Cell,Inhibitor, Cell Growth,Inhibitor, Growth,Inhibitors, Cell Growth,Inhibitors, Growth
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Tomohisa Baba, and Sari Iwasaki, and Takako Maruoka, and Akira Suzuki, and Utano Tomaru, and Hitoshi Ikeda, and Takashi Yoshiki, and Masanori Kasahara, and Akihiro Ishizu
April 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Tomohisa Baba, and Sari Iwasaki, and Takako Maruoka, and Akira Suzuki, and Utano Tomaru, and Hitoshi Ikeda, and Takashi Yoshiki, and Masanori Kasahara, and Akihiro Ishizu
January 2004, Comparative hepatology,
Tomohisa Baba, and Sari Iwasaki, and Takako Maruoka, and Akira Suzuki, and Utano Tomaru, and Hitoshi Ikeda, and Takashi Yoshiki, and Masanori Kasahara, and Akihiro Ishizu
September 2001, Journal of immunology (Baltimore, Md. : 1950),
Tomohisa Baba, and Sari Iwasaki, and Takako Maruoka, and Akira Suzuki, and Utano Tomaru, and Hitoshi Ikeda, and Takashi Yoshiki, and Masanori Kasahara, and Akihiro Ishizu
March 2004, Cancer gene therapy,
Tomohisa Baba, and Sari Iwasaki, and Takako Maruoka, and Akira Suzuki, and Utano Tomaru, and Hitoshi Ikeda, and Takashi Yoshiki, and Masanori Kasahara, and Akihiro Ishizu
April 2017, Scientific reports,
Tomohisa Baba, and Sari Iwasaki, and Takako Maruoka, and Akira Suzuki, and Utano Tomaru, and Hitoshi Ikeda, and Takashi Yoshiki, and Masanori Kasahara, and Akihiro Ishizu
February 2005, Journal of immunology (Baltimore, Md. : 1950),
Tomohisa Baba, and Sari Iwasaki, and Takako Maruoka, and Akira Suzuki, and Utano Tomaru, and Hitoshi Ikeda, and Takashi Yoshiki, and Masanori Kasahara, and Akihiro Ishizu
January 2016, Medecine sciences : M/S,
Tomohisa Baba, and Sari Iwasaki, and Takako Maruoka, and Akira Suzuki, and Utano Tomaru, and Hitoshi Ikeda, and Takashi Yoshiki, and Masanori Kasahara, and Akihiro Ishizu
September 2013, Cancer immunology research,
Tomohisa Baba, and Sari Iwasaki, and Takako Maruoka, and Akira Suzuki, and Utano Tomaru, and Hitoshi Ikeda, and Takashi Yoshiki, and Masanori Kasahara, and Akihiro Ishizu
February 1997, European journal of immunology,
Tomohisa Baba, and Sari Iwasaki, and Takako Maruoka, and Akira Suzuki, and Utano Tomaru, and Hitoshi Ikeda, and Takashi Yoshiki, and Masanori Kasahara, and Akihiro Ishizu
October 2002, Journal of leukocyte biology,
Copied contents to your clipboard!